Hutch News

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover

From the Emerman and Henikoff Labs, Pathogen Associated Malignancies and Cancer Basic Biology Programs, Cancer Consortium.
Science SpotlightSeptember 19, 2022
Uncovering the secrets of HIV latency

Uncovering the secrets of HIV latency

From the Cohn lab, Vaccine and Infectious Disease Division
Science SpotlightNovember 15, 2021
Modeling the kinetics of an HIV cure

Modeling the kinetics of an HIV cure

From the Schiffer group, Vaccine and Infectious Disease Division
Science SpotlightFebruary 15, 2021
Herpesvirus infections may affect the size of the HIV reservoir in ART-treated children

Herpesvirus infections may affect the size of the HIV reservoir in ART-treated children

From the Lehman lab, Human Biology Division, and the Department of Global Health at the University of Washington
Science SpotlightNovember 16, 2020
Suppressing immunity to fight HIV infection

Suppressing immunity to fight HIV infection

From the Jerome lab, Vaccine and Infectious Disease Division
Science SpotlightNovember 16, 2020
Fred Hutch honors local HIV cure activists, volunteers

Fred Hutch honors local HIV cure activists, volunteers

Seattle's defeatHIV Community Advisory Board receives impact award
Hutch NewsJanuary 24, 2020
Persistent HIV infection works a lot like cancer, study shows

Persistent HIV infection works a lot like cancer, study shows

Ecology-inspired analysis suggests why reservoirs of HIV linger in treated patients
Hutch NewsNovember 19, 2018
One step closer to the Berlin Patient and an HIV cure

One step closer to the Berlin Patient and an HIV cure

Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Science SpotlightJune 18, 2018